Addition of Vincristine and Irinotecan to Vincristine, Dactinomycin, and Cyclophosphamide Does Not Improve Outcome for Intermediate-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group.
暂无分享，去创建一个
James R. Anderson | S. Donaldson | D. Rodeberg | S. Spunt | S. Skapek | D. Hawkins | W. Meyer | T. Yock | E. Rudzinski | L. Teot | D. Parham | C. Arndt | S. Wolden | G. McCowage | J. McCune | Yueh-Yun Chi | M. B. McCarville | M. Shnorhavorian | C. Morris | A. Hayes-Jordan | Jing Tian | L. Mascarenhas | L. Bomgaars | L. Million